Navigation Links
National Institute Of Health & Family Welfare To Commercialize Its Products

A Memorandum of Agreement was signed today between the National Institute of Health & Family Welfare (NIHFW) and National Research Development Corporation (NRDC) for transfer of technology developed by the NIHFW in the fields of Thermo Stable Elisa Kits and Laboratory Kits for Testing Sperm Functions. The up scaling of technologies developed by the Institute will be taken up by NRDC for commercialization. Prof. Deoki Nandan, Director, NIHFW and Mr. Somenath Ghosh, Chairman & Managing Director, NRDC signed the Memorandum of Agreement. This is the first time that the technology developed by NIHFW is being taken up for commercialization.

Thermo Stable Elisa Kits technology allows enzyme conjugate and antibody to retain their enzymatic and immunological activity respectively at 37oC for three months or more than two years at 2 to 8oC. The thermo stability technology for enzyme conjugate can have applicative value in those Elisa kits that are based on the use of enzyme horseradish peroxidase as label. The imported kits wherein horseradish peroxidase enzyme used are not thermo stable (can not with stand higher temperature of 37oC for more than twenty four hours). They require cold chain for their transport and storage. The new technologies are useful in production of Thermo-Stable Elisa Kits.

Three technological kits have been developed for testing Sperm functions. These will help to test many of the specialized functions of the sperms which otherwise are not routinely examined. It will strengthen the existing diagnostic tools in the male infertility diagnosis and management. It has the great potential to be routinely used in human sperm banks and can be extended in the same area for veterinary applications. At present no such laboratory kit for sperm function is available in the market. The kits do not require any imported material and have been developed indigenously.

In addition, the institute has also developed a vaginal co ntraceptives technology, which is water based, very much effective, less expansive and expected to provide wide acceptability.


'"/>




Related medicine news :

1. National Lung Study in the process
2. Indian Nationals with Foreign Medical Degrees can now practice in India
3. Hepatitis B Vaccine To Be Included In National Immunization Programme
4. UK Govt Says On Course For National Chlamydia Screening
5. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
6. India extends National TB Control Program
7. President and Founder of National Obesity Forum Resigns
8. Hwang Woo Suk Suspended By Seoul National University
9. Indian National in Saudi Jail will be released soon
10. National Women and Girls HIV/AIDS Awareness Day
11. Calcutta National Medical College Strike Continues Unabated
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... Newport Beach, Calif. (PRWEB) , ... April 29, 2016 , ... ... affect us. An effective way to confront and deal with these stressors is to ... taste bad to be good for you. Risa Groux, a certified Holistic Nutritionist and ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... more flexibility in repaying their loans, more information about their loan terms and ... total outstanding student loan debt, including federal and private loans, has reached $1.3 ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Spine Team ... pain, is proud to announce one of their physicians has been invited to be ... Physicians (Texas ACOFP) Family Practice Review conference on April 30, 2016. , Dr. ...
(Date:4/29/2016)... ON (PRWEB) , ... April 29, 2016 , ... ... and the Canadian Celiac Association (CCA), is pleased to announce the launch of ... gluten-free products, nutritional articles, recipes, and more. The purpose of the GFCP ...
(Date:4/29/2016)... ... , ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a ... throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , ... patented safety device secured by nasal surgeons onto the floor of the nasal passages, ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)... , April 28, 2016 ... "Global Plastic Surgery Products Market 2016-2020" report ... ) , The global plastic surgery ... of 9.47% during the period 2016-2020. , ,The growing ... leading to the growth of the market. Lasers are ...
(Date:4/28/2016)... 28, 2016 Treato , ... healthcare, announced today that it has been named a ... Vendor in Life Sciences, 2016, Stephen Davies ... report focuses on life-science- oriented analytics, algorithms and smart ... and doctors, confirm medication ingestion, and analyze unstructured information. ...
Breaking Medicine Technology: